Two-year-old incubator and seed fund 1776 helps startups make government connections in Washington, D.C., and now it’s setting up shop in San Francisco to strengthen its links to Silicon Valley’s VCs.
Its new outpost is at Hattery, a co-working studio... Read more »
Blueprint Medicines of Cambridge, MA, is the latest biotech to raise more cash than expected in an IPO. The developer of experimental cancer therapies sold 8.15 million shares at $18 apiece Wednesday evening, bringing in nearly $147 million, according to research... Read more »
The Bullitt Center earlier this month lived up to its billing as the world’s greenest commercial office building. It earned certification through the Living Building Challenge after a year of operations in which the six-story, timber-framed edifice—and its tenants—consumed less energy... Read more »
The latest demo day for New York’s Entrepreneurs Roundtable Accelerator was a step forward, but more work lies ahead for the program and the city.
“A lot has changed since 2011 for all of New York tech,” said Jonathan Axelrod, a... Read more »
Any expectant parent knows that preeclampsia—a kind of high blood pressure during pregnancy—is a dreaded possibility. It can be fatal for mother and baby, and it can be difficult to diagnose.
Matthew Cooper (pictured) knows the danger all too well, nearly... Read more »
The healthcare technology-focused venture capital firm formerly known as Foundation Medical Partners is rebranding as Flare Capital Partners. The new name coincides with the close of a new $200 million fund, from which Flare has already made five investments, according... Read more »
Viking Therapeutics (NASDAQ: VKTX) said its shares are expected to begin trading today, after the San Diego biopharmaceutical raised $24 million in its initial public offering last night by selling 3 million shares at $8 a share. The price fell... Read more »
Search for information about Infinidat, the latest data storage company founded by industry legend Moshe Yanai, and you’ll come up with surprisingly little. At least, you would until today.
That’s likely to change after Infinidat announced Wednesday it has raised... Read more »
Celgene (NASDAQ: CELG) is paying $30 million for the right to acquire a brand-new biotech, Northern Biologics, that is the first product of a Toronto incubator that the big Summit, NJ, drugmaker has helped fund.
Northern is developing protein therapies,... Read more »